Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1995
10/05/1995WO1995026347A1 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents
10/05/1995WO1995026342A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026334A1 Substituted azetidinone compounds useful as hypocholesterolemic agents
10/05/1995WO1995026188A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
10/05/1995WO1995018618A3 Enteral formula with ribo-nucleotides
10/05/1995CA2186606A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
10/05/1995CA2186389A1 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them
10/05/1995CA2186381A1 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents
10/05/1995CA2184754A1 5h-indeno[1,2-b]pyrazine-2,3-dione derivatives, preparation thereof and drugs containing same
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/04/1995EP0675121A1 Novel intermediates and processes for preparing benzothiophene compounds
10/04/1995EP0675120A2 Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
10/04/1995EP0675110A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors
10/04/1995EP0674903A1 Raloxifene for inhibiting bone loss and lowing serum cholesterol
10/04/1995EP0674902A1 Method of improving the immune response
10/04/1995EP0674714A1 Recombinant canine gastric lipase and pharmaceutical compositions
10/04/1995EP0674641A1 Pyrrolopyrimidines as crf antagonists
10/04/1995EP0674626A1 Novel selective aromatase inhibiting compounds
10/04/1995EP0674514A1 Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives
10/04/1995EP0674509A1 Methods for treatment with dimercaptosuccinic acid (dmsa)
10/04/1995EP0674508A1 4-guanidinobutyramide for improving blood circulation
10/04/1995CN1109364A Insulin formulation
10/04/1995CN1109331A Methods of inhibiting obsessive-compulsive and consumptive disorders
10/04/1995CN1109330A Methods of inhibiting imperfect tissue repair
10/04/1995CN1109329A Preparation for beta-carotene or carotene micro capsule and its application thereof
10/03/1995US5455329 DNA sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/03/1995US5455273 N,N-disubstituted arylcycloalkylamines, the salts thereof, pharmaceutical compositions containing these compounds and the use thereof and processes for preparing them
10/03/1995US5455265 For mammals; skin disorders, cancer, inflammatory disease, cardiovascular diorders, autoimmune diseases and others
10/03/1995US5455233 Detectors, antiinflammatory, antilipemic agents and antitumor agents
10/03/1995CA2065093C Remedies for bone diseases
10/02/1995CA2145346A1 Cosmetic or dermatological compositions and process for preparing them
10/01/1995CA2145614A1 Intermediates and processes for preparing benzothiophene compounds
09/1995
09/28/1995WO1995025749A2 Eating suppressant peptides
09/28/1995WO1995025726A1 QUINAZOLINYL-AMINO DERIVATIVES HAVING α-ANTAGONIST ACTIVITY
09/28/1995WO1995025721A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025548A2 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives
09/28/1995WO1995025532A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
09/28/1995WO1995025522A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
09/28/1995WO1995025519A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives
09/28/1995DE4410822A1 Neue Piperidin-Derivate New piperidine derivatives
09/28/1995DE4410601A1 Neue 2.4-Diphosphonoglutarsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New 2.4-Diphosphonoglutarsäurederivate, process for their preparation and pharmaceutical compositions containing them
09/28/1995CA2186010A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/28/1995CA2185450A1 Eating suppressant peptides
09/27/1995EP0673932A1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments
09/27/1995EP0673931A1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments
09/27/1995EP0673930A1 Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as medicaments
09/27/1995EP0673929A1 Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments
09/27/1995EP0673913A1 Calcium-alkali-citrate compounds and their use as medicaments
09/27/1995EP0521103B1 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
09/27/1995EP0348490B1 Treatment of type 2 diabetes mellitus
09/27/1995CN1109050A Catecholamine surrogates useful as beta3 agonists
09/27/1995CN1108944A Microbiological medicine containing rich selenium for health-care and therapy and its preparation
09/26/1995US5453524 Phosphorus-containing isoprenoid derivatives
09/26/1995US5453442 Chromene derivative
09/26/1995US5453429 Crosslinked anion exchange particles and method for producing the particles
09/26/1995US5453419 Xenopus laevis bone morphogenetic proteins and use thereof
09/26/1995US5453417 Process for the phosphorylation of insulin and product produced thereby
09/26/1995US5453282 Dietary lipid digestion-absorption inhibitory agents and ingesta
09/26/1995CA2145476A1 Sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation, and their use as pharmaceuticals
09/26/1995CA2145475A1 Sulfonamidocarbonylpyridine-2-carboxesteramides and their pyridine-n-oxides, process for their preparation, and their use as pharmaceuticals
09/26/1995CA2145473A1 Substituted heterocyclic carboxamidoesters their preparation and their use as pharmaceuticals
09/26/1995CA2145472A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
09/26/1995CA1337128C Propanamine derivatives
09/21/1995WO1995025104A1 Novel heterocyclic ethanolamine derivatives with beta-adrenoreceptor agonistic activity
09/21/1995WO1995024920A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
09/21/1995WO1995024915A1 Product and process for regulating signal transduction pathways
09/21/1995WO1995024909A1 Osteoporosis preventing or treating agent
09/21/1995WO1995024906A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
09/21/1995WO1995024895A1 Uses of perillyl alcohol and perillic acid methyl ester
09/21/1995WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
09/21/1995DE3490636C2 New double-bond isomer of 1-alpha, 25-di:hydroxy:vitamin=D-2
09/21/1995CA2185425A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
09/21/1995CA2185324A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995CA2184631A1 Product and process for regulating signal transduction pathways
09/20/1995EP0672660A2 Substituted cyclohexanol-esters, their use to treat illnesses and pharmaceutical preparations
09/20/1995EP0672412A2 Use of 3,4-diphenyl chromans for the manufacture of a medicament for lowering cholesterol levels
09/20/1995EP0672119A1 Retroviral mediated transfer of the human multiple drug resistance gene
09/20/1995EP0672060A1 Antigen associated with type i diabetes mellitus
09/20/1995EP0672057A1 Analogs of pth
09/20/1995EP0672054A1 A novel molecule which inhibits neuropeptide tyrosine biological function
09/20/1995EP0671949A1 USE OF $g(b)-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
09/20/1995EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION
09/20/1995EP0671922A1 Fluidized intestinal submucosa and its use as an injectable tissue graft
09/20/1995EP0671910A1 Glaucoma treatment
09/20/1995EP0671907A1 Composition and method for inducing satiety
09/20/1995EP0479813B1 Novel methylenebisphosphonic acid derivatives
09/20/1995CN1108662A Method of producing reconstituted lipoproteins
09/19/1995US5451688 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses
09/19/1995US5451677 Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
09/19/1995US5451596 Cycloalkyl amine bis-aryl squalene synthase inhibitors
09/19/1995US5451573 Substituted cyclohexane derivatives for the treatment of diseases
09/19/1995US5451397 Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels
09/14/1995WO1995024495A1 Transgenic production of oligosaccharides and glycoconjugates
09/14/1995WO1995024473A1 Vascular endothelial growth factor 2
09/14/1995WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995WO1995024411A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995WO1995024400A1 Thiazolidinedione derivatives as anti-hyperglycemic agents
1 ... 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 ... 1298